Navigation Links
Axiomed is Raising Interest from Silicon Valley

Aditya Humad, Acting CFO of AxioMed and Managing Partner of KICVentures, is pleased to announce that in addition to Australia, Europe, and the United States, Axiomed is now gaining interest from Silicon Valley. “It was satisfying to complete the due diligence required to assure interest in this technology."

Mr. Humad went on to say that, “We expect interest to continue to rise as AxioMed completes its cleanroom assembly to begin manufacturing the cervical and lumbar viscoelastic disc for international distribution to meet an anticipated high demand.” AxioMed completed its IDE in August 2016 and is preparing a submission to the FDA for the clearance of its viscoelastic lumbar disc.

Dr. Kingsley R. Chin, Acting CEO of AxioMed and Managing Partner at KICVentures has been spending more time in Silicon Valley and is quoted as saying, “I feel I share a lot in common with the entrepreneurs in Silicon Valley. I have a tremendous respect for their accomplishments in a broad range of technologies and I feel they have a lot of respect for my knowledge, track record, and experience in health technology. Experts in Silicon Valley have expressed the importance of the potential disruption the seems eminent within healthcare. Time and time again, I get the feedback that AxioMed’s viscoelastic technology seems intuitive over all other existing technologies for spine surgery. They also feel that the clinical and biomechanical results so far are very convincing. I expect interest to build as we demonstrate continued progress.”

About AxioMed
Founded in 2001, AxioMed ( began its journey of exhaustively proving the Freedom® Disc through clinical studies in the USA and Europe, research, development and testing. In 2014, KICVentures recognized the disc’s enormous potential and acquired the company into their healthcare portfolio. AxioMed owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology.

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. AxioMed Continues International Push with Visit to German Surgeons to Discuss Viscoelastic Total Disc Replacement Technology
2. AxioMed Expanding International Presence with Visit to Swiss Surgeons
3. First AxioMed Viscoelastic Total Disc Replacement Implanted in Australia
4. AxioMed Making International Push by Displaying Viscoelastic Total Disc Replacement at Cervical Spine Research Society in Toronto
5. Five Things Clinical Studies Are Showing about AxioMed’s Next-Generation Freedom® Total Disc Replacement
6. St. Baldricks Foundation Sets $50,000 Goal for Giving Tuesday Fundraising Challenge
7. KAHR Medical Reports Raising $12M at First Closing of Its Series B Private Equity Financing
8. PCI Ventures Company Liquid Biotech USA, Inc. Announces Raising $2M in Seed Capital to Develop its Proprietary Platform Technology for Cancer Diagnostics and Gene Discovery
9. GW Pharmaceuticals plc Announces Pricing of U.S. Public Offering of ADSs Raising $179.2 Million on NASDAQ Global Market
10. CargoSense Completes Seed Round Offering By Raising $2.5 Million
11. Documentary Film that Follows Singularity University Students as They Change the World Launches its IndieGoGo Fundraising Campaign
Post Your Comments:
(Date:12/18/2019)... ... ... Tune in to CNBC on Saturday, December 28th at 11:00aET to watch a ... on this program. , With a look at Avatar Partners , Advancements will ... the efficiency, safety and effectiveness of equipment, systems, and processes for the Warfighter, First ...
(Date:12/6/2019)... (PRWEB) , ... December 06, ... ... manufacturer Vascular Medcure, Inc. has received FDA 510(k) clearance for its latest ... company’s early clinical data suggests the CAPERE® offers great benefits for first-in-line ...
(Date:12/4/2019)... ... 03, 2019 , ... Absolute Antibody Ltd. , an ... the Recombinant Antibody Network (RAN), a consortium of three expert centers at the ... common goal to generate recombinant antibodies at a proteome-wide scale. Under the new ...
(Date:12/4/2019)... ... , ... A new study released today in STEM CELLS outlines how fat ... tissue) buildup – also improves the range of motion of the affected limb. The ... , The tumor-destroying capabilities of radiation therapy can be a life saver for ...
Breaking Biology Technology:
(Date:12/30/2019)... ... December 30, 2019 , ... It’s been quite a ... seen its highest sales in 2019, having hosted a multitude of team-building events and ... visited the company’s La Jolla-based venue, and the company has worked hard to accommodate ...
(Date:12/18/2019)... ... December 17, 2019 , ... PM360, a ... and diagnostics industries, has named Pharmafusion LLC as one of the most innovative ... company and its founder/CEO Jonathan Retano. Earlier in the year, Pharmafusion was featured ...
(Date:12/4/2019)... ... December 03, 2019 , ... Genedata, ... Agenus , a clinical-stage immuno-oncology company developing therapies to fight cancer, has ... platform. Agenus will use the platform to support immunotherapy and vaccine pipeline programs ...
Breaking Biology News(10 mins):